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Abstract
Background: Reprogramming of somatic cells for derivation of either embryonic stem (ES) cells, by somatic cell nuclear
transfer (SCNT), or ES-like cells, by induced pluripotent stem (iPS) cell procedure, provides potential routes toward non-
immunogenic cell replacement therapies. Nucleolar proteins serve as markers for activation of embryonic genes, whose
expression is crucial for successful reprogramming. Although Nucleolin (Ncl) is one of the most abundant nucleolar proteins,
its interaction partners in ES cells have remained unidentified.
Methodology: Here we explored novel Ncl-interacting proteins using in situ proximity ligation assay (PLA), colocalization
and immunoprecipitation (IP) in ES cells.
Principal Findings: We found that phosphorylated Ncl (Ncl-P) interacted with translationally controlled tumor protein (Tpt1)
in murine ES cells. The Ncl-P/Tpt1 complex peaked during mitosis and was reduced upon retinoic acid induced
differentiation, signifying a role in cell proliferation. In addition, we showed that Ncl-P interacted with the transcription
factor Oct4 during interphase in human as well as murine ES cells, indicating of a role in transcription. The Ncl-P/Oct4
complex peaked during early stages of spontaneous human ES cell differentiation and may thus be involved in the initial
differentiation event(s) of mammalian development.
Conclusions: Here we described two novel protein-protein interactions in ES cells, which give us further insight into the
complex network of interacting proteins in pluripotent cells.
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Introduction
Nuclear reprogramming of somatic cells is a promising route in
cell replacement therapy that can be used to replace or restore
normal function of damaged cells. The ultimate approach is to
reprogram the patient’s own cell, which would avoid immuno-
suppression. The molecular mechanisms of nuclear reprogram-
ming are still unsolved although recent reports have shown that
reprogramming of human somatic cells can be achieved in vitro by
retroviral expression of four transcription factors creating induced
pluripotent stem (iPS) cells, which are comparable to ES cells
[1,2,3,4]. One factor has been proven essential for successful iPS
cell creation i.e. Oct4, which is an established ES cell [5,6] and
potent nuclear reprogramming factor [7,8,9]. Successful repro-
gramming of somatic cells requires proper embryonic genome
activation. In rhesus monkey, the major embryonic genome
activation is thought to occur between the six- and eight-cell
stages, which coincide with the timing of nucleogenesis [10]. The
nucleolus may therefore serve as a marker for embryonic genome
activation.
Nucleolin (Ncl, also denoted C23), one of the most abundant
non-ribosomal proteins in the nucleoli, is a multifunctional protein
[11], which belongs to a large family of RNA binding proteins and
is a substrate to several kinases. Extensive phosphorylation occurs
during interphase on serine residues by CK2 [12], while cdc2
phosphorylate threonine residues during mitosis [13], and these
phosphorylation patterns regulate Ncl functions and localization
during the cell cycle.
Ncl is functionally hyperactive in rapidly dividing cells
compared to nondividing cells, and high levels of Ncl are found
in tumors [14] and other rapidly dividing cells such as ES cells
[15,16], indicating several important functions during cell
proliferation. A unique regulatory mechanism for Ncl expression
has been revealed; Ncl has increased stability in proliferating cells
by inhibiting its self-cleaving activity [17]. Down-regulation
experiments using RNA-interference has proven that Ncl is
essential for cell division, given that absence of Ncl results in
prolonged cell cycle with misaligned chromosomes, defects in
spindle organization [18], growth arrest and increased apoptosis
[19]. Ncl has also been reported to have a cell cycle-controlled
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protein (Rb), only occurring during G1 when Rb is unpho-
sphorylated and this interaction inhibits the DNA binding function
of Ncl and determines its cellular localization [20]. ES cells possess
a unique cell cycle quite different from committed cells [21],
especially G1 is shortened and Rb is hyperphosphorylated during
the whole cell cycle, indicating that Ncl should not be influenced
or in a complex with Rb in ES cells.
Ncl is also described to interact with or be part of several
transcription factor complexes, one of them being the B cell-
specific transcription factor and switch region binding protein,
LR1 [22]. Ncl has been shown to activate endogenous Bcl-2 and
CD34 gene expression in CD34 positive hematopoietic cells by a
direct sequence-specific interaction with the CD34 promoter
region and is thus involved in the maintenance of these
progenitor/stem cells in hematopoiesis [23].
Even though Ncl is expressed at high levels in ES cells, not
much is known about its specific role or physical interaction
network in this cell type; therefore we explored Ncl in ES cells,
starting with a search for new interaction partners. In current
study, we show that Ncl interacts individually with translationally
controlled tumor protein (Tpt1) and Oct4 in a cell cycle dependent
manner, and both complexes require phosphorylation of Ncl.
Results
Identification of Ncl as a possible Tpt1 interaction partner
in ES cells
We have previously reported that translationally controlled
tumor protein (Tpt1) physically interacts with nucleophosmin
(Npm1) in murine ES cells in a cell cycle specific manner [24]. In
the same screen, using recombinant Tpt1 covalently linked to
cyanogen bromide activated sepharose beads, incubated with total
ES cell extract, several proteins were eluted with increasing ionic
strength. The eluted fractions at 1.0 M NaCl were separated by
SDS-PAGE, and stained with coomassie brilliant blue dye. Bands
(1–6, lane 1, Figure 1A) were excised from the gel and proteins
were identified by nano-LC FT-ICR mass spectrometry. Band 2
was uniquely identified as nucleolin (Ncl) (Figure 1B), and the Ncl/
Tpt1 interaction was further investigated.
Ncl/Tpt1 colocalization depends upon phosphorylation
of Ncl and peaks during mitosis
In order to examine if endogenous Tpt1 and Ncl colocalize at
different stages of the cell cycle, we employed immunofluorescence
analyses using confocal microscopy. Colocalization is visualized in
a negligible amount in the nucleoli (Figure 2A). Since both
proteins have been implicated to be important during cell division,
cells were arrested in metaphase by addition of demecolcine, and
stained with antibodies against phosphorylated nucleolin (anti-Ncl-
P) and anti-Tpt1 (Figure 2B, see Figure S1, for comparison of anti-
Ncl and anti-Ncl-P in interphase and mitotic cells, and specificity
of anti-Ncl on western blot). Substantially more colocalization is
visualized with Ncl-P/Tpt1 (Figure 2B–C) compared to Ncl/Tpt1
(Figure 2A). Comparison of the amount of colocalization of the
Ncl-P/Tpt1 interaction in mitotic (Figure 2B) and interphase cells
(Figure 2C) reveals that the colocalization is most prominent
during mitosis.
To quantify the observed Ncl/Tpt1 colocalization differences
between mitotic and interphase cells we calculated three different
parameters: Pearson’s correlation coefficient, percentage overlap
of Tpt1 and percentage overlap of Ncl or Ncl-P. Tpt1 and Ncl
were as expected confirmed not to colocalize (Table 1, first row)
whereas Tpt1 and Ncl-P were confirmed to colocalize both in
mitotic (Table 1, second row) and interphase (Table 1, third row)
ES cells as indicated by good values of all three parameters but
with significantly higher values for mitotic cells.
In brief, Tpt1 and Ncl only colocalize when Ncl is phosphor-
ylated and Ncl-P/Tpt1 colocaliztion peaks during mitosis.
Ncl-P/Tpt1 colocalization decreases upon differentiation
To investigate whether Tpt1 and Ncl-P colocalize in differen-
tiated cells, ES cells were induced to differentiate by retinoic acid
treatment for up to 72 h. To obtain sufficient number of mitotic
Figure 1. Identification of Ncl as a possible Tpt1 interaction
partner. (A) Whole ES cell extract was incubated with sepharose-linked
Tpt1 and bound proteins were eluted with increasing ionic strength.
Lane 1–4 represents different fractions from the 1.0 M NaCl elute. Bands
of interest (numbered 1–6, lane 1) were excised and identified by
peptide sequencing, which gave the following results: 1. Myosin heavy
polypeptide 9; 2. Nucleolin; 3. Actin, cytoplasmic type 8, c-actin, b-actin;
4. Ribosomal protein L10, Tropomyosin; 5. H1d, H1e, H1b, Ribosomal
protein small subunit, Tropomyosin; and 6.H 1 a ,T r o p o m y o s i n ,
ribosomal protein L8. (B) Nano-LC FT-ICR mass spectrometry uniquely
identified band number 2 as nucleolin. Sequences of 15 peptide
fragments from the excised band are shown.
doi:10.1371/journal.pone.0013678.g001
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Undifferentiated ES cells were compared to cells treated with
retinoic acid for 24, 48 and 72 h, respectively, and Pearson’s
correlation coefficient was found to significantly decrease after
72 h of retinoic acid induced differentiation (Table S1). These
analyses imply that Tpt1 interacts with Ncl-P in ES cells, and that
the Ncl-P/Tpt1 interaction decreases upon differentiation.
Ncl-P co-immunoprecipitates with anti-Tpt1 in murine ES
cells
To assess the Ncl-P/Tpt1 interaction, mitotic extracts from
murine ES cells were subjected to co-immunoprecipitation with
anti-Tpt1 followed by Western blot. Ncl-P was immunoprecipated
with anti-Tpt1 (Figure 2D, IP Tpt1: 1 M NaCl). No co-
immunoprecipitation of Ncl-P was detected in the IgG control.
These findings show that Ncl-P can be immunoprecipitated
together with anti-Tpt1 in mitotic murine ES cell extract, further
confirming that Ncl-P interacts with Tpt1 in ES cells.
Ncl-P physically interacts with Tpt1 in ES cells
In situ proximity ligation assay (PLA) [25] was used to explore
the interaction between Ncl-P and Tpt1 in further detail. The
distance between the primary antibodies needs to be less than
40 nm for the PLA to generate a signal, making the methodology
highly specific for physically interacting protein-protein complex-
es, and this method works in fact very well in our cell system [24].
Anti-Ncl-P is an IgM antibody, and the PLA method works best
with IgG antibodies, therefore both IgM anti-Ncl-P and two IgG
anti-Ncl (recognizing both unphosphorylated and phosphorylated
forms of Ncl) were used in different experiments to explore the
Ncl-P/Tpt1 interaction. Quite few Ncl/Tpt1 complexes are seen
in the nucleoplasm of interphase cells when using anti-Ncl (sc-
8031) (Figure 2E). The second anti-Ncl (sc-13057) didn’t render
any Ncl/Tpt1 complexes at all (data not shown). Considerable
higher amounts of Ncl-P/Tpt1 complexes are seen in the three
cells arrested in metaphase by demecolcine (Figure 2F). Even
though anti-Ncl-P is an IgM antibody and therefore less detected
than IgG, the PLA still verifies that the Ncl-P/Tpt1 interaction
occurs mostly during mitosis, which confirms the observation
made by immunofluorescence analyses, and also establishes that
endogenous Ncl-P physically interacts with endogenous Tpt1
especially in mitotic cells. (See Figure S2 for positive and negative
controls).
Ncl-P colcoalize with Oct4 during interphase in ES cells
The staining pattern of Ncl-P in interphase cells (Figure S1B)
shows very similar staining pattern as the stem cell marker Oct4,
and since both proteins are involved in transcription we
investigated if they interact in ES cells. In order to examine if
endogenous Ncl-P and Oct4 colocalize, we employed immuno-
fluorescence studies using confocal microscopy. High colocaliza-
tion is detected in the nucleoplasm (Figure 3A). To quantify that
the colocalization is significant we analyzed the cells with the
BioPix iQ 2.0 software. Table 1 (fourth row) indicates really good
colocalization with both a high Pearson’s correlation coefficient
and also good percentage overlap from both proteins. These
analyses indicate that Oct4 and Ncl exist in a complex in murine
ES cells when Ncl is phosphorylated, and show really prominent
pattern of interaction in interphase ES cells.
Oct4 physically interacts with Ncl-P in both human and
murine ES cells
To further explore the endogenous interaction between Oct4
and Ncl-P in situ PLA was used. Both anti-Ncl and anti-Ncl-P were
tested in different experiments. With anti-Ncl-P reasonable
number of Ncl-P/Oct4 complexes are seen in the nucleoplasm
of the interphase murine ES cells (Figure 3B), and the same
complex pattern was observed with anti-Ncl (sc-13057) (Figure 3C)
while hardly any signal was rendered using anti-Ncl (sc-8031) (data
not shown). All together this confirms the immunofluoresence
results and furthermore proves that Ncl-P/Oct4 physically interact
in ES cells.
Table 1. Phosphorylated Ncl interacts individually with Tpt1 and Oct4.
Variables Pearson’s correlation coefficient % overlap of Ncl or Ncl-P % overlap of Tpt1 or Oct4
Interphase Ncl/Tpt1 0.24960.004 10.8560.57 5.5660.13
Mitotic Ncl-P/Tpt1 0.76160.013 43.4462.65 69.6663.05
Interphase Ncl-P/Tpt1 0.52460.008 38.7361.51 18.6465.06
Interphase Ncl-P/Oct4 0.81560.005 65.6262.59 33.0061.87
Ncl only interacts with Tpt1 when phosphorylated and the Ncl-P/Tpt1 interaction is most prominent during mitosis. Ncl-P also shows interaction with Oct4 during
interphase. Data are represented as mean 6 SEM.
doi:10.1371/journal.pone.0013678.t001
Figure 2. Ncl/Tpt1 interaction which peaks during mitosis and requires phosphorylations on Ncl. (A–C) Immunofluorescence confocal
microscopy analysis of ES cells. DNA was counterstained with DAPI (blue). (A) ES cell colony reveals Ncl (green) nucleolar staining, whereas Tpt1 (red)
localize ubiquitously in the cells. Visualization of colocalization (white) reveals that there are negligible amounts of Ncl/Tpt1 colocalization in the
nucleolar compartments (see enlargement in lower left corner). (B) ES cells, arrested in metaphase by addition of demecolcine, shows that the
nucleolar compartment is disassembled in mitotic cells at the same time as Ncl is phosphorylated (green) and the expression pattern more resembles
Tpt1 (red) in the mitotic cells. Ncl-P/Tpt1 shows high degree of colocalization (white) during mitosis. (C) Confocal laser transmission of the green
channel was increased to be able to visualize the lower amounts of Ncl-P (green) also during the interphase of the cell cycle and as shown there are
some minor amounts of Ncl-P/Tpt1 colocalization (white) in this stage. (D) Co-immunoprecipitation experiments followed by Western blot analysis
show that Ncl-P can be immunoprecipitated using anti-Tpt1 but not with IgG (eluted with1 M NaCl or citrate). (E–F) Immunofluorescence confocal
microscopy in combination with in situ PLA, which is highly specific for detecting physically interacting protein-protein complexes (red). DNA was
counterstained with Hoechst 33342 (blue). (E) A few Ncl/Tpt1 complexes are shown in the nucleoplasm of ES cells, in accordance with colocalization
results in (D). (F) A rather high amount of Ncl-P/Tpt1 complexes are shown in the mitotic cells arrested with demecolcine, in accordance with
colocalization results in (C). Scale bar represents 10 mm.
doi:10.1371/journal.pone.0013678.g002
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murine ES cells or if it also exists in human ES cells (hESC). Since
Oct4 showed no difference in complex formation between anti-
Ncl-P and anti-Ncl in murine ES cells, together with that in situ
PLA works best with IgG antibodies, we used anti-Ncl (sc-13057)
to examine the interaction between Ncl-P/Oct4 in hESCs.
Figure 3. Endogenous Ncl-P/Oct4 interaction during interphase in ES cells. (A) ES cells showing similar staining of Ncl-P (green) and Oct4
(red) in the nuclei of interphase cells. Visualization of colocalization (white) reveals that Ncl-P/Oct4 colocalization is detected mostly in the
nucleoplasm. DNA was counterstained with DAPI (blue). (B–E) Immunofluorescence confocal microscopy in combination with in situ PLA, detects Ncl-
P/Oct4 complexes (red) in the nucleoplasm of both murine ES cells and hESCs. DNA was counterstained with Hoechst 33342 (blue). (B) Although
using IgM anti-Ncl-P that is less detected than IgG with the in situ PLA, still a substantial number of Ncl-P/Oct4 complexes is observed in the
nucleoplasm of murine ES cells,which confirm their interaction. (C) Using anti-Ncl (recognizing both unphosphorylated and phosphorylated forms of
Ncl) the same complex pattern of Ncl/Oct4 complexes is seen spread out in the nucleoplasm of murine ES cells. (D) One small hESC with a number of
Ncl/Oct4 complexes in the nucleoplasm confirms that the interaction also exists in hESCs. (E) Three larger hESCs, probably cells that have started to
differentiate, show really high amounts of Ncl/Oct4 complexes in the nucleoplasm, while no complexes are observed in the nucleoli (seen as empty
round spaces in the cells), confirming that Ncl needs to be phosphorylated to interact also with Oct4. Scale bar represents 10 mm.
doi:10.1371/journal.pone.0013678.g003
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complexes, indicating that the interaction also exists in hESCs.
The most interesting observation is that in hESCs that have started
to spontaneously differentiate (cells are growing bigger) have really
high amount of Ncl/Oct4 complexes (Figure 3E), implying that
the interaction may be important during initial differentiaiton.
(See Figure S2, for positive and negative controls for in situ PLA).
This observation could not be seen in murine ES cells, even
though ES cell cultures contain some cells that have started to
spontaneously differentiate. All three cells visualized in Figure 3E
lack red dots in the compartments that corresponds to the nucleoli,
strengthening our finding that Oct4 only interacts with Ncl when
phosphorylated, since Ncl-P are restricted to the nucleoplasm of
interphase cells, while unphosphorylated Ncl are restricted to the
nucleoli (Figure S1B).
To conclude, Oct4 and Ncl-P interact in interphase cells in both
human and murine ES cells and the interaction increases during
spontaneous differentiation of hESCs.
Discussion
The data presented here reveals new protein-protein complexes
involving Ncl in murine and human ES cells, where we have
identified Oct4 and Tpt1 as two endogenous Ncl-P interaction
partners. All experiments with murine ES cells were performed on
two different ES cell lines (R1 and RW4) in parallel. We found no
discernible differences between the EScelllines, and one experiment
also included human ES cells, indicating our findings to be generally
applicable for ES cells, and not species or cell line specific.
In our previous search for Tpt1 interaction partners in ES cells
[24] we found that Tpt1 forms a complex with Npm1. In the same
screen additional potential interaction partners were found. One
of the factors found were actin, which has recently been reported
to interact with Tpt1 [26] and we have now also revealed that Ncl-
P forms a complex with Tpt1 in murine ES cells. Ncl has
previously been reported to be expressed at high levels in both
murine [15] and human ES cells [16] where high levels of Tpt1
also were reported. Recent proteome analysis of mouse ES cell
lines has furthermore revealed that the presence of Tpt1 is a
characteristic of undifferentiated ES cells [27]. Tpt1 is well
conserved and expressed in all eukaryotic organisms but no main
function has yet been found.
Accumulating evidence demonstrate that Tpt1 and Ncl are
important for cell proliferation. Tpt1 is up-regulated during the
entry into the cell cycle. Over-expression of Tpt1 results in slow
growing cells and a delayed cell cycle progression [24,28] whereas
over-expression of a Tpt1 double mutant, in which the two Plk1
phosphorylation sites have been substituted for alanines, induced a
dramatic increase in multinucleated cells, rounded cells with
condensed ball-like nuclei, and cells undergoing cell death [29].
Down-regulation experiments using RNA-interference have
shown that Ncl is required for correct mitosis, given that absence
of Ncl gave a prolonged cell cycle with misaligned chromosomes
and defects in spindle organization [18]. Similar experiments
revealed that absence of Ncl forced cells into growth arrest,
accumulated in G2 phase, but also resulted in increased apoptosis
and effects on the nucleus as well as defects in centrosome
duplication [19].
According to the above we reasoned that the found interaction
between Ncl-P/Tpt1, which peaks during mitosis, plays a part in
cell proliferation or cell cycle regulation. This is further supported
by that we found the colocalization to decrease upon retinoic acid
induced differentiation, since differentiated cells proliferate much
slower than ES cells.
We previously found an interaction between Tpt1 and Npm1
[24] that also showed a cell cycle dependent pattern of interaction
with a significant peak during mitosis. Ncl and Npm1 have
previously been shown to be interaction partners [30]. One could
speculate if all three proteins may exist in a complex during
mitosis, but we do not think this is the case. Npm1/Ncl was
previously shown not to interact during prometaphase and
metaphase [30], phases where we detect individual interactions
of Ncl-P/Tpt1 and Tpt1/Npm1, suggesting that they are not part
of a single complex.
Remarkably, we found that Ncl-P also forms a complex with
Oct4andweobserve this complexduringinterphaseinbothmurine
and human ES cells. Oct4 (also denoted Oct3, Pou5f1, and NF-A3)
belongs to the POU transcription factor family. POU transcription
factors were originally identified as DNA-binding proteins that are
able to activate the transcription of genes containing an octameric
sequence called the octameric motif (AGTCAAAT), within the
promoter or enhancer region. Oct4 has been proven to be essential
for the identity of the pluripotential founder cell population in the
mammalian embryo [5]. Its endogenous expression is normally
tightly restricted to embryonic stem and germ cells, and illegitimate
Oct4 activation is also typical for embryonic carcinoma cells [5,31].
The precise levels of Oct4 expression was reported to determine the
fate of ES cells to either differentiate, dedifferentiate or self-renew
[6]. Oct4 has also been reported to be a potent nuclear
reprogramming factor, where the Oct4 distribution and level in
mouse clones showed consequences for pluripotency and the
development of the somatic cell clones [7]. With the newest method
to reprogram somatic cell nuclei through retroviral introduction by
different sets of transcription factors to create iPS cells, Oct4 has
again been proven to be one of the necessary components for
successful nuclear reprogramming [1,2,3,4].
Ncl has been described to interact with or be a component of
several transcription factor complexes, one of them being the B
cell-specific transcription factor and switch region binding protein,
LR1 [22]. LR1 has previously been shown to regulate c-myc
transcription in B-cell lymphomas [32] and Ncl has independently
been found to be a c-myc target gene, were the c-Myc oncoprotein
induces the levels of Ncl [33]. The LR1 binding site
(CCTCCTGGTCAAGGCTGAA) shows some interesting simi-
larities to the octameric motif, with five of the eight bases being
exactly the same, and the base proceeding and descending these
five bases can be altered without LR1 losing its binding activity
[34]. Even more interesting is that LR1-binding activity was also
reported to be dependent on phosphorylations of LR1 [35] and
our found interaction between Oct4 and Ncl is only occurring
when Ncl is phosphorylated, indicating a similar mechanism for
Ncl-P/Oct4 as components of a transcription factor complex in
ES cells. All the above implies that Ncl-P is a component of a
transcription factor complex together with Oct4 in ES cells.
Although further investigations are required to verify this, by for
example chromatin immunoprecipitation on sequences where
Oct4 are known to bind, although none of our anti-Ncl works on
immunoprecipitation so unfortunately we have not been able to
perform the necessary experiments and can only speculate about
it. Most interesting is the observed increase of Ncl-P/Oct4
complexes in spontaneously differentiated hESCs. It is tempting
to speculate that Ncl-P works as a repressor to the activity of Oct4,
by forming complexes with it when the ES cells start to
differentiate. This might either allow transcription of genes
repressed by Oct4 in ES cells or inhibit ES cell specific
transcription.
To conclude, we have identified two new interaction partners to
Ncl in ES cells, both interactions occurring when Ncl is
Ncl Interactions in ES Cells
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mitosis and the interaction decreases upon retinoic acid induced
differentiation; this indicates of a roll in cell proliferation or cell
cycle regulation of rapidly dividing cells. Ncl-P/Oct4 interact in
the nucleoplasm of interphase cells in both murine and human ES
cells and show increased interaction in the beginning of
spontaneously differentiated human ES cells. Similarities are
found in the literature of Oct4 and Ncl binding sites as
transcription factors, highly proposing Ncl-P to be together with
Oct4 in a transcription factor complex in ES cells and that the
complex formation is increasing during the initiation of sponta-
neous differentiation. Regarding our data here we propose Ncl-P
as a connecting link between proliferation and transcription.
Expression of Ncl-P may therefore improve reprogramming of
somatic cells.
Materials and Methods
Tpt1 interaction partner screen
Plasmid construction, expression and purification of recombi-
nant Tpt1, preparation of sepharose-linked Tpt1 and screen for
new interaction partners with ES cell extracts was performed
according to previously published material [24].
Cell culture
Cell lines were grown at 37uC in a humidified atmosphere
containing 5% CO2. Murine ES cell lines RW4 [36] (derived from
129X1/SvJ) and R1 [37] (derived from 129X1 x 129S1) were
maintained on mitomycin C inactivated mouse embryonic
fibroblasts in Dulbecco’s modified eagle’s medium supplemented
with 15% fetal calf serum, 1.0 mM sodium pyruvate, 0.1 mM
nonessential amino acids, 2.0 mM L-glutamine, 0.1 mM b-
mercaptoethanol, 100 U/100 mg penicillin/streptomycin, 20 mM
HEPES pH 7.3 and 1000 U/ml leukemia inhibitory factor. Human
ES cell line SA461 [38] was cultured and provided from Cellartis
AB (Go ¨teborg, Sweden).
Cell extracts
Whole cell extracts were prepared by harvesting confluent cell
cultures containing approximately 3610
7 cells. Harvested cells
were incubated in ice cold extraction buffer (10 mM Tris-HCl
pH 7.4, 10 mM MgCl2, 10 mM KCl, 1.0 mM DTT) containing
protease inhibitor cocktail tablet (Complete, Roche Diagnostics)
for 10 min, 4uC. The addition of NP40 to 1% (v/v) was followed
by incubation for 10 min, 4uC. Cell lysates were homogenized and
NaCl was added to a final concentration of 420 mM followed by
incubation for 1 h, 4uC. The extracts were cleared by centrifu-
gation (19,000xg, 1 h, 4uC) and the supernatant was frozen and
stored in liquid nitrogen.
Western blot
Proteins were separated using SDS-PAGE, followed by semi-dry
electrotransfer onto polyvinylidene difluoride membranes for 1 h,
100mA/gel in transfer buffer (48 mM Tris, 39 mM Glycin,
1.3 mM SDS, 10% methanol) and immunologically detected.
Membranes were blocked with 5% skim milk in phosphate-
buffered saline (PBS) containing 0.1% Tween 20 for 1 h and
incubated with primary antibody (anti-TCTP [ab37506, Abcam],
anti-TG3 against phosphorylated nucleolin [kind gift from Peter
Davies]) in blocking solution overnight at 4uC. After washing with
PBS-Tween, blots were incubated with secondary antibody (AP
conjugated goat anti-mouse IgM+IgG+IgA (H+L) [Southern
Biotechnology Associates] or HRP-conjugated anti rabbit IgG
[NA934VS, Amersham Biosciences]) in blocking solution for 1 h
at room temperature. Visualization of proteins was done with
BCIP/NBT kit (Invitrogen) or Pierce ECL Western Blotting
Substrate (Nordic Biolabs).
Co-immunoprecipitation
Co-immunoprecipitation was performed with Dynabeads Pro-
tein G (Invitrogen) according to the manufacturer’s protocol by
addition and crosslinking with dithiobispropionimidate-2HCl of
10 mg polyclonal anti-TCTP [ab37506, Abcam] or normal IgG
antibody [sc-2027, Santa Cruz]. Mitotic extracts were prepared by
arresting ES cells in metaphase by adding Demecolcine (0.02 mg/
ml, Invitrogen) 14 h prior to extract preparation. Mitotic extracts
were incubated with the antibody-beads over night, 4uC. Proteins
were eluted in 1 M NaCl (50 mM Tris pH 7.5, 1.0 M NaCl, 0.1%
NP40, 1.0 mM DTT) with the use of the magnet. Extended
elution, where antibodies were eluted, was done with 0.1 M
Citrate with the use of the magnet. Elutes were mixed with 2x
Laemmli buffer and heated to 95uC for 5 min and analyzed by
Western blot.
Immunofluorescence analyses and confocal microscopy
5–8610
4 cells were grown on glass coverslips overnight.
Metaphase arrest was achieved by incubation with 0.02 mg/ml
demecolcine (Invitrogen) for 14 h and differentiation was achieved
by incubation with 2.0 mM retinoic acid for up to 72 h. Cells were
fixed in 4% paraformaldehyde/PBS for 20 min, permeabilized
with 0.25% Triton X-100/PBS for 5 min, and blocked in 5%
normal goat serum or 10% fetal calf serum in 0.1% Triton X-100/
PBS for 20 min. Primary (anti-HRF/TPT1 [Code No. M099-3,
Clone 6E9, Nordic Biosite]; anti-C23 [sc-13057 or sc-8031, Santa
Cruz]; anti-Oct-3/4 (H-134): sc-9081 [Santa Cruz]; anti-Oct4
[611203, Clone 40, BD Biosciences]; anti-TG3 against phosphor-
ylated nucleolin [kind gift from Peter Davies]) and secondary
(Alexa Fluor 488 or 555 labeled goat anti-mouse IgG or IgM;
Alexa Fluor 488 or 555 labeled goat anti-rabbit IgG [Molecular
Probes]) antibodies diluted in 0.1% Triton X-100/PBS/0.5%
normal goat serum or 1% fetal calf serum were sequentially added
for 2 and 1 h, respectively, each followed by washes in 0.1%
Triton X-100/PBS. Nuclei were counterstained with 4,6-diami-
dino-2-phenylidole (DAPI). Coverslips were air-dried, mounted,
and analyzed using an inverted Zeiss LSM 510 META confocal
microscope equipped with a Zeiss image processing system. An
636/1.4 oil NA objective and sequential scanning with narrow
band-pass filters was used (BP 420–480 for DAPI, 505–530 for
Alexa 488 and BP 560–615 for Alexa 555).
Colocalization analysis
Colocalization was visualized using ImageJ (http://rsb.info.nih.
gov/ij). Confocal micrographs were collected at 0.38 mM intervals
to create z-axis stacks, and images rendered from the z-axis stacks
were analyzed with the BioPix iQ 2.0 software. Mitotic and
interphasecells wereselectedmanually.A minimum of fivedifferent
z-axis stacks, containing at least 10 cells each, were taken for each
analysis. Data are represented as mean6SEM (standard error of
mean). SPSS 13.0 was used for statistical evaluation of colocaliza-
tion results generated by BioPix iQ 2.0. One-way analysis of
variance followed by post hoc and Turkey’s test, were done to
evaluate significant changes between groups. Values are considered
significant if p # 0.01 for the differences between analyzed groups.
Generic in situ proximity ligation assay
324610
4 cells were grown on chamber slides overnight.
Fixation, permeabilization, blockage and primary antibody (anti-
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HRF (FL-172): sc-30124 [Santa Cruz]; anti-C23 [sc-13057 or sc-
8031, Santa Cruz]; anti-Oct-3/4 (H-134): sc-9081 [Santa Cruz];
anti-Oct4 [611203, Clone 40, BD Biosciences]; anti-TG3 against
phosphorylated nucleolin [kind gift from Peter Davies]) incubation
were performed as decribed for immunofluorescence analyses.
Duolink (Olink Biosciences) in situ proximity ligation assay (PLA)
was performed according to the manufacturer’s protocol. PLA
probes were diluted in 0.1% Triton X-100/PBS/1% fetal calf
serum and incubated in a pre-heated humidity chamber for 1 h at
37uC, followed by hybridization, ligation, amplification and
detection. Nuclei were counterstained with Hoescht 33342. Slides
were analyzed by confocal microscopy.
Supporting Information
Figure S1 Endogenous Ncl vs. Ncl-P in ES cells. (A) ES cells
arrested at metaphase by addition of demecolcine solution. Ncl
(green) is mostly visible in the nucleolar compartment; meanwhile
the Ncl-P (red) is highly expressed only in the cells that are arrested
in mitosis. (B) Confocal laser transmission of the red channel was
increased to be able to visualize the lower amounts of Ncl-P (red)
in the interphase cells. Compared to Ncl (green), Ncl-P shows no
staining in the nucleolar compartment, but is visualized in the
nucleoplasm, best visualized in the merge picture. DNA was
counterstained with DAPI (blue). Scale bar represents 10 mm. (C)
Western blot showing the specificity of anti-Ncl (sc-13057), only
giving one band in the right size (approximately 110 kDa).
Found at: doi:10.1371/journal.pone.0013678.s001 (3.87 MB TIF)
Figure S2 In situ proximity ligation assay controls. (A-B) Positive
control for in situ PLA. Immunofluorescence confocal microscopy
in combination with in situ PLA, detects Npm1/Ncl complexes
(red) in both murine ES cells (A) and hESCs (B). Ncl/Nmp1 was
used as a positive control since their interaction has been
demonstrated previously [Liu, H. T., and Yung, B. Y. (1999) In
vivo interaction of nucleophosmin/B23 and protein C23 during
cell cycle progression in HeLa cells. Cancer Lett 144, 45-54]. (C-E)
Negative controls for murine ES cells (C & E) and hESCs (D) to
visualize in situ PLA background staining when no primary
antibodies were used (C-D) and Nanog-Ncl (E), which do not
interact in ES cells. A few red dots did appear but in consideration
of the amount obtained in the experiments, it can be neglected.
DNA was counterstained with Hoechst 33342. Scale bar
represents 10 mm.
Found at: doi:10.1371/journal.pone.0013678.s002 (10.18 MB
TIF)
Table S1
Found at: doi:10.1371/journal.pone.0013678.s003 (0.04 MB
DOC)
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